What Grade 3–4 cartilage damage means for your knee

An MRI report that mentions 'Grade 3' or 'Grade 4' cartilage damage is not an automatic sentence to knee replacement — but it does mark the point where the damage is serious enough to demand a clear plan.

The ICRS (International Cartilage Repair Society) scale grades cartilage loss from 0 (normal) to 4 (most severe). Grade 3 lesions extend more than 50% of the cartilage's full depth, reaching down toward or through the calcified layer just above the subchondral bone — but the bone plate beneath remains intact. Grade 4 means the defect has broken through that plate entirely. Think of it like a pothole: Grade 3 is a deep crater that has nearly eaten through the road surface; Grade 4 is one that has broken through to the foundation layer.

This depth distinction matters clinically because it directly shapes which repair routes are feasible. Grade 3 itself is subclassified as 3A through 3D, with 3C and 3D sitting at the calcified-layer boundary — biologically reparable in principle, but mechanically demanding. Grade 4 involves the subchondral bone and generally requires an approach that addresses both cartilage and bone together.

The second critical number is the area of the defect. Clinical evidence and established practice bifurcate at roughly 2–4 cm², with different technique tiers appropriate above and below that threshold.

Equally important is whether the damage is focal — a discrete lesion surrounded by healthy cartilage borders — or diffuse. Healthy borders are the prerequisite for any restorative procedure; once disease is spread across a compartment, focal repair tools lose their foothold.

Grade alone cannot be determined from symptoms. MRI with cartilage-sensitive sequencing, including T2 mapping where available, is needed to stage the lesion accurately before any treatment plan is made. The rest of this article follows those three axes — depth, area, and extent of disease — to map the options from repair through to replacement.

Cartilage repair options — and which defect size each suits

Defect area is the primary sorting axis for repair technique selection — and the technique hierarchy follows it closely.

Under approximately 4 cm²

OATS / mosaicplasty transfers plugs of cartilage and bone from a lower-load-bearing part of the knee directly into the defect — a single-stage surgical procedure with long-term comparative data supporting better outcomes than microfracture. The meaningful limitation is donor-site morbidity: harvesting plugs elsewhere in the joint creates a secondary wound, and available supply constrains how large a mosaic pattern is feasible.

The ChondroFiller injectable collagen scaffold — delivered as an ultrasound-guided outpatient injection rather than in an operating theatre — suits suitable focal defects up to approximately 3 cm², with clinical evidence data noting use up to 6 cm² in some cases. Rather than harvesting tissue from elsewhere, the scaffold recruits the patient's own progenitor cells through matrix-induced chondrogenesis. Published outcome data from the clinical evidence report show IKDC score improvements of approximately +30 points and MOCART scores of 70–87 (on a 0–100 scale where higher values indicate better cartilage fill). It occupies the same size bracket as mosaicplasty but represents a non-surgical pathway — distinct in route and mechanism — for patients where that approach is clinically appropriate.

Approximately 2–10 cm²

AMIC (autologous matrix-induced chondrogenesis) combines marrow stimulation with a biological scaffold in a single procedure. In a matched-cohort comparison, 92% of AMIC patients were positive Lysholm responders at 2–4 years, against 64% for minced cartilage implantation.

MACI (matrix-induced ACI) is a two-stage cell-based technique. The SUMMIT randomised trial established its superiority over microfracture for defects ≥3 cm² at both 2 and 5 years. A systematic review of 168 patients with a minimum 10-year follow-up recorded a TKA conversion rate of only 7.4% — making MACI the most durably evidenced biologic repair option currently in the published literature at this time horizon.

Above 4 cm²

Fresh osteochondral allograft (OCA) addresses large or structurally complex defects using donor tissue. Published survivorship for isolated large focal lesions reaches 82.6% at 5 years and 69.6% at 10 years — honest benchmarks for shared decision-making.

Microfracture: historical context only

Microfracture — once the default opening move — ranked last across every comparison in a network meta-analysis of 21 randomised trials involving 891 patients: higher failure rates than ACI at 10 years, more poor results than MACI, and fibrocartilage breakdown within 2–3 years. It also risks damaging the subchondral bone plate in ways that can close off future repair options. It does not feature here as a current first-line choice.

One emerging development — single-treatment ACI (STACI) — aims to collapse the two-stage ACI process into a single session, though long-term outcome data remain limited at this stage.

Osteotomy — correcting alignment to protect the repair

Fixing the cartilage without addressing a malaligned knee is like repairing a road while leaving the lorries driving over the same damaged lane. High tibial osteotomy (HTO) corrects varus (bow-legged) alignment; distal femoral osteotomy (DFO) addresses valgus (knock-kneed) deformity. Both work by cutting and reshaping the bone to shift the mechanical axis away from the cartilage-damaged compartment, reducing peak contact stress where it is already most destructive.

Osteotomy is not a cartilage treatment in itself — its job is to create the mechanical conditions in which a repair has a realistic chance of surviving long-term.

What the evidence says about combining the two

A study of 199 patients established a clinically important conditionality: adding a cartilage procedure to HTO produced significantly better pain and function scores than isolated HTO alone — but only in patients who achieved well-regenerated cartilage at second-look arthroscopy. Patients with poorly-regenerated cartilage did no better than those who had the osteotomy alone. That finding is relevant to informed consent: the benefit of the combined operation depends on the quality of what the cartilage repair delivers.

Technique choice within the repair component also matters at this stage. In a 92-patient trial, microdrilling combined with HTO produced superior MOCART cartilage scores at 12 months and better early pain and function compared with classic microfracture combined with HTO — though most score differences converged by 24 months.

Age is not a bar

Osteotomy is sometimes seen as a younger-patient strategy, but a published series of patients aged 60 and over with spontaneous osteonecrosis of the knee and defects of 4 cm² or larger — treated with ACI combined with HTO — recorded KOOS improving from 38.4 to 77.8 at one year, with near-normal or normal arthroscopic cartilage appearances in 91% of cases and no postoperative complications.

Depending on surgical planning and defect characteristics, osteotomy may precede, accompany, or occasionally follow the cartilage procedure. That sequencing decision is made at consultation stage on a case-by-case basis.

Large and complex defects — when fresh osteochondral allograft fits

Autograft supply runs out. A single OATS plug suits a small focal defect; even a mosaicplasty pattern has practical limits. Once a lesion exceeds roughly 4 cm² — or when damage affects both opposing cartilage surfaces simultaneously (bipolar or 'kissing' lesions) — fresh osteochondral allograft (OCA) provides the structural bone-and-cartilage replacement that biologic repair alone cannot match at that scale.

Bipolar lesions: honest survivorship

The survivorship figures for large bipolar lesions are lower than for isolated focal defects, and patients should have these numbers before surgery. In a published series of 89 knees with a mean defect area of 16.7 cm² and mean patient age 37.9 years, OCA showed survivorship of 73.8% at 5 years, 66.6% at 10 years, and 58.9% at 15 years, with graft failure in 34.8% of knees overall. Among grafts remaining in situ — 65.2% of the cohort — functional scores were maintained at a mean follow-up of 11.3 years.

After failed index surgery

When a prior cartilage procedure has not held, OCA is typically the next biologic option. A systematic review of 349 patients (mean age 34.6 years, mean secondary defect 5.8 cm²) found an overall failure rate of 16.6% and 5-year survival of 79–87.8%. Defect size was the strongest predictor of failure: lesions reaching 9–10 cm² approached a 39% failure rate alongside a 67% reoperation rate.

A bridge, not a permanent answer

For patients in their thirties or forties facing defects too large for cell-based repair, OCA may extend the joint-preservation window considerably. Where multi-surface Grade IV defects were treated with OCA combined with MACI or DeNovo in a series of 35 patients, only 2 failures occurred at approximately 39 months and more than half met the minimum clinically important difference across all KOOS and IKDC domains. The survivorship curves nonetheless make clear that arthroplasty cannot always be avoided — individual suitability depends on defect geometry, bone stock, and alignment, assessed at consultation.

The gap between repair and replacement — what sits in between

The PRRR framework — Preserve, Repair, Regenerate, Replace — describes a continuum rather than four discrete boxes, and for many Grade 3–4 patients the honest answer is that they sit somewhere in the middle stages, without a clean algorithm directing them one way or the other.

Where focal repair runs out

Every cartilage repair technique depends on healthy margins to build against. When Grade 4 changes become diffuse — spread across the broader surface rather than a single demarcated lesion — those margins disappear, and marrow stimulation, cell-based implants, and osteochondral grafts all lose their structural foothold. The literature does not yet define precisely where that boundary lies; identifying it requires cartilage-sensitive imaging, load analysis, and arthroscopic findings, not grade alone.

The UKA question in younger patients

Unicompartmental arthroplasty enters the framework when cartilage loss is diffuse within one compartment but the remaining compartments are sound. Direct comparative data between UKA and joint-preserving cartilage procedures in patients under 55 is an acknowledged evidence gap; neither pathway has been shown definitively superior in this group, and the decision rests on compartmental involvement, alignment, and realistic activity demands.

Orthobiologics as adjuncts

Bone marrow mesenchymal stem cells have shown clinically relevant improvements in pain and function across 33 studies covering 724 patients (mean age 44.2 years) — though average methodology quality was 55 out of 100, which limits certainty. At this stage of disease, BM-MSCs are most plausibly useful as part of a restorative strategy rather than as a structural substitute for grafting when healthy margins have been lost.

Emerging single-stage options

AMIC variants and injectable scaffold techniques — including needle-delivered autologous chondrogenic approaches that compress a two-stage process into a single outpatient session — are specifically targeting this middle-ground population. Long-term durability data for these newer one-stage methods remains limited; they represent active clinical development rather than an established evidence base.

For someone in their late thirties with a 5 cm² diffuse Grade 4 lesion, no standard protocol determines the route. Load analysis, cartilage-sensitive MRI, and compartmental assessment at consultation allow the individual variables — mechanical axis, bone stock, biological age, and activity goals — to be mapped against what each option can realistically deliver.

Getting a Grade 3–4 cartilage assessment at Lincolnshire Knee

Accurate staging — defect depth, area, location, and mechanical axis — underpins every treatment decision discussed in this article. A standard MRI report tells you a lesion exists; it does not reveal how load distributes across that compartment during movement, or whether an alignment problem is the primary driver of ongoing damage. For Grade 3–4 disease, a complete assessment combines cartilage-sensitive MRI with AI-driven segmentation and T2 mapping (onMRI™) to characterise lesion geometry precisely, and objective gait and biomechanical biomarker analysis (MAI Motion®) where malalignment or load distribution is part of the clinical picture — both interpreted alongside full consultant review of the joint's compartmental involvement.

Lincolnshire Knee is part of the MSK Doctors group and accepts patients without a GP referral. Consultations are available at Sleaford NG34 and Grantham NG31; to arrange an assessment, visit lincolnshireknee.co.uk.

1. [1] Multi-Surface Cartilage Defects about the Knee Treated with Cartilage Restoration Procedures Show Good Outcomes and Survivorship at Minimum 2-Year Follow-Up. (2023). https://doi.org/10.1177/19476035231207780 https://doi.org/10.1177/19476035231207780
2. [2] Minimum 10-Year Outcomes of Matrix-Induced Autologous Chondrocyte Implantation in the Knee. (2024). https://doi.org/10.1177/03635465231205309 https://doi.org/10.1177/03635465231205309
3. [3] Meta-Analysis and Evidence Base for the Efficacy of Autologous Bone Marrow Mesenchymal Stem Cells in Knee Cartilage Repair. (2019). https://doi.org/10.1155/2019/3826054 https://doi.org/10.1155/2019/3826054
4. [4] Autologous Chondrocyte Implantation Combined with High Tibial Osteotomy for Spontaneous Osteonecrosis of the Knee with a Relatively Large Cartilage Lesion in Elderly Patients. (2025). https://doi.org/10.1177/19476035251392531 https://doi.org/10.1177/19476035251392531
5. [5] Midterm Survivorship and Clinical Outcomes in Fresh Osteochondral Allograft Transplantation for the Treatment of Large Bipolar Lesions of the Knee. (2025). https://doi.org/10.1177/03635465241313139 https://doi.org/10.1177/03635465241313139
6. [6] Clinical Benefits of Cartilage Repair in High Tibial Osteotomy Can Only Be Expected in Patients with Successfully Regenerated Cartilage. (2025). https://doi.org/10.4055/cios24409 https://doi.org/10.4055/cios24409
7. [7] The Clinically Important Difference and Patient Acceptable Symptomatic State for Commonly Used Patient-Reported Outcomes After Knee Cartilage Repair. (2020). https://doi.org/10.1177/0363546520969883 https://doi.org/10.1177/0363546520969883
8. [8] Surgical Techniques for Knee Cartilage Repair: An Updated Large-Scale Systematic Review and Network Meta-analysis of Randomized Controlled Trials. (2020). https://doi.org/10.1016/j.arthro.2019.11.096 https://doi.org/10.1016/j.arthro.2019.11.096
9. [9] Osteochondral Allograft Transplantation as a Salvage Procedure After Failed Index Cartilage Surgery of the Knee: A Systematic Review. (2025). https://doi.org/10.1177/03635465241238466 https://doi.org/10.1177/03635465241238466
10. [10] Comparison of Clinical, Radiologic, and Arthroscopic Outcomes Between Microfracture and Microdrilling Techniques for Articular Cartilage Defects in Medial Opening-Wedge HTO. (2025). https://doi.org/10.1177/23259671241309372 https://doi.org/10.1177/23259671241309372